Suketu Upadhyay Elected to Vertex Board of Directors
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Suketu (“Suky”) Upadhyay has been elected to its board of directors...
Month: May 2022
Study Reveals Comedy, AI, and Self-Care Can Quickly Boost Patient Mental Health
Dramatic Reduction in Depression, Stress, and Anxiety Reported NEW YORK and WASHINGTON and PALO ALTO, Calif. and TENAFLY, N.J., May 18, 2022 /PRNewswire/...
Proxima Clinical Research Client, Airway Shield™, Receives STeP Designation for Endotracheal Intubation Device that Protects Patients and Clinicians
Device reduces the spread of infection from patients to clinicians during aerosol generating procedures like intubation of COVID-19 patients, among...
Bulletin From The 2022 Annual General Meeting Of Spago Nanomedical Ab (Publ)
LUND, SE / ACCESSWIRE / May 18, 2022 / Spago Nanomedical (STO:SPAGO.ST) (FRA:7UX.F)The Annual General Meeting (AGM) of Spago Nanomedical...
Altamira Therapeutics Issues Shareholder Letter
Highlights Company's progress to becoming a pure-play RNA business and tech strategy and penetrate the multi-billion TAMHAMILTON, BERMUDA / ACCESSWIRE...
Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the First Quarter of 2022
Reports Positive Net Income of $0.2 Million and $1.2 Million of EBITDA for the First Quarter of 2022CHICAGO, IL /...
Sorrento Therapeutics, Inc. Appoints Former Roche Executive Tammy Reilly to the Board of Directors
SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc (Nasdaq: SRNE, “Sorrento”), a commercial and clinical-stage biopharmaceutical company dedicated...
Capricor Therapeutics to Present at the H.C. Wainwright Global Investment Conference
SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of...
FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis
Lund May 18, 2022 - Active Biotech AB (Nasdaq Stockholm: ACTI) today announced that the U.S. Food and Drug Administration...
Grow Therapy Survey Reveals 97% of Therapists Say the Number of People Seeking Therapy Post-Pandemic for the First Time has Increased
Social Media Plays a Role in Damaging One’s Mental Health, but Therapists Say News Consumption is Even Worse 1:1 Time...
Ceapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate Update
– Best quarterly financial results in history of the Company – Q1 2022 sales of $6,172,000 vs $4,702,000 in Q1...
INmune Bio, Inc. to Present at the H.C. Wainwright Global Hybrid Investment Conference on May 24th
Boca Raton, FL, May 18, 2022 (GLOBE NEWSWIRE) -- INmune Bio (NASDAQ: INMB), a clinical stage immunology company focused on...
Novateur Ventures Participates in Founding and Financing of Epitopea, a New Cancer Therapeutics Company
The Newly Founded Company, Epitopea, Has Secured $14 Million in Seed Financing to Advance the Ground-breaking Tumor-Specific Antigen (TSA) Research...
AVEO Oncology Announces Participation at the H.C. Wainwright Global Investment Conference
BOSTON, May 18, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that...
ChemoCentryx Announces Presentation at the Society for Investigative Dermatology Meeting Highlighting the Role of Tunnels in Driving Ongoing Disease in Hidradenitis Suppurativa
-- Supports plans to advance TAVNEOS®(avacopan) into Phase III development for the treatment of patients with most severe form of...
Veru Announces Appointment of Joel Batten to Lead U.S. Infectious Disease Franchise to Focus on Hospitalized COVID-19 Patients
MIAMI, May 18, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for...
Kane Biotech Obtains ISO 13485 Certification
The quality management system of Kane is certified for design and development of medical devicesWINNIPEG, Manitoba, May 18, 2022 (GLOBE NEWSWIRE)...
Fortress Biotech to Participate in Two Upcoming May 2022 Investor Conferences
MIAMI, May 18, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently...
Senti Bio Highlights Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells in Three Presentations at ASGCT Annual Meeting
- SENTI-202 oral presentation details systematic optimization of Logic Gating Gene Circuit technology in allogeneic CAR-NK cells to more precisely...
Patient Experience Survey Reported Positive Findings for GIMOTI®
Research Study Among Patients Demonstrated Favorable Acceptance and Utilization of GIMOTISOLANA BEACH, Calif. and CHICAGO, May 18, 2022 (GLOBE NEWSWIRE)...